Healthcare MoneyTree™ report: Q4 2018

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.

PwC and CB Insights' Healthcare MoneyTree™ report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.

For full analysis of Q4’18 activity across all sectors, refer to the PwC/CB Insights MoneyTree™ Report.

US Healthcare deal share by stage

Early and expansion stage deals made up the majority of deals.

 

Highlights for this quarter's report include, but are not limited to:

  • Median deal size for expansion and seed stage companies increased, hitting $22.0M and $3.2M respectively.
  • The Biotechnology subsector led the Healthcare industry in Q4’18 in terms of dollars invested, raising $978M, a 55% decrease from Q3’18 raising $2,168M.
  • New England is above Silicon Valley in dollars invested in Q4’18, with $1,348M raised this quarter through 28 deals.
  • New England held 33% of the US Healthcare market share for total deal dollars invested in Q4’18, while Silicon Valley accounted for 26% of total deal dollars. Together, both regions accounted for more than half of the total deal dollars in the country this quarter.

Contact us

Greg Vlahos

Partner, US Pharmaceuticals and Life Sciences , PwC US

Tel: +1 (408) 817 5029

Laura Robinette

US Pharmaceutical & Life Sciences Assurance Leader, PwC US

Tel: +1 (919) 791 4100

Tim Weld

US Health Industries Assurance Leader, PwC US

Tel: +1 (917) 882 9274

Follow us